1. Home
  2. BMA vs TLX Comparison

BMA vs TLX Comparison

Compare BMA & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Macro S.A.  ADR (representing Ten Class B)

BMA

Banco Macro S.A. ADR (representing Ten Class B)

HOLD

Current Price

$88.59

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$7.63

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMA
TLX
Founded
1966
2015
Country
Argentina
Australia
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
3.3B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
BMA
TLX
Price
$88.59
$7.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$96.33
$21.00
AVG Volume (30 Days)
247.0K
197.8K
Earning Date
02-25-2026
01-15-2026
Dividend Yield
2.39%
N/A
EPS Growth
N/A
N/A
EPS
0.26
0.04
Revenue
$1,943,401,172.00
$664,225,558.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.56
N/A
P/E Ratio
$35.98
$237.31
Revenue Growth
N/A
55.35
52 Week Low
$38.30
$7.49
52 Week High
$118.42
$30.36

Technical Indicators

Market Signals
Indicator
BMA
TLX
Relative Strength Index (RSI) 54.65 31.75
Support Level $90.07 $7.49
Resistance Level $93.49 $8.22
Average True Range (ATR) 3.67 0.22
MACD -0.53 -0.05
Stochastic Oscillator 55.41 7.77

Price Performance

Historical Comparison
BMA
TLX

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: